Dr Rudenko has significant research background in allergy and asthma. His MD PhD projects were on sub-lingual specific immunotherapy in children, adolescents and adults; he did many studies in asthma, allergy, medical mycology and immunology of herpes viruses and large number of Phase 2-3 trials as sub/co-investigator, principal investigator.
He obtained 2 patents for his work in developing new schemes of treatment of recurrent herpes virus infection and prevention of CMV and EBV infection. Dr Rudenko is a Member of American Academy of Allergy Asthma and Immunology AAAAI where he served as a board member on Allergen Standardization and Allergy Diagnostics Committee as well as Practice Management Committee and an individual member of FOCIS Federation of Clinical Immunology Societies.
Dr Rudenko participates in EAACI-Task Force for EAACI-UEMS Knowledge Examination in Allergy and Immunology and provided many questions that are currently used in European Exam in Allergy and Immunology. Dr Rudenko published over 10 original articles, 2 editorials in peer-reviewed journals, over 35 scientific abstracts. In addition, he participated in 3 position papers, as well as publishing over 5 review articles, 3 book chapters, 1 monograph, some publications are in press and did more than 15 invited presentations at international meetings during the last five years.